TRPV2 and prostate neoplasm: Silencing of TRPV2 by small interfering RNA diminishes the expression of degrading enzymes MMP2, MMP9, and cathepsin B and decreases the formation of metastasis in PC3 prostate tumours established in mice xenografts and bladder tumour development and progression (Monet et al., 2010; Liu and Wang, 2013).